We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......

Basic View | Expanded View
 Showing 1-12 of 12 Articles
Viewpoint  FREE
Steven R. Cummings, MD; Stephanie Studenski, MD, MPH; Luigi Ferrucci, MD, PhD
Slow gait limits independence, decreases quality of life, and is associated with an increased risk of disability, hospitalization, placement in long-term care,1,2 and accelerated clinical progression of many chronic diseases, including chronic obstructive pulmonary disease, diabetes, congestive heart failure, and dementia. Slow gait speed is also a predictor of all-cause ...
Topics: mobility
Medical News & Perspectives  FREE
Bridget M. Kuehn, MSJ
Since mid-January, the nurses at the Coastal Cancer Center in Myrtle Beach, South Carolina, have been spending several hours each week tracking down suppliers who can provide the intravenous (IV) solutions necessary for patients scheduled to receive chemotherapy. If they are unsuccessful, Vijay Paudel, MD, an oncologist at the facility, ...
Research Letter  FREE
Michelle H. Moniz, MD; Matthew M. Davis, MD, MAPP; Tammy Chang, MD, MPH, MS
Access to contraception improves maternal and child health.1 The Patient Protection and Affordable Care Act (ACA) requires most private health insurance plans to cover contraception without a shared patient cost to improve access. However, debate continues about applying the contraception coverage mandate to public corporations that object on religious grounds2,3; ...
Viewpoint  FREE
Rahul Rajkumar, MD, JD; Patrick H. Conway, MD, MSc; Marilyn Tavenner, RN, MHA
Includes: Supplemental Content
The Affordable Care Act created the Center for Medicare and Medicaid Innovation (Innovation Center) to test innovative payment and service delivery models to reduce program expenditures under Medicare, Medicaid, and the Children’s Health Insurance Program (CHIP) and to enhance the quality of care that Centers for Medicare & Medicaid Services ...
Viewpoint  FREE
Andrew M. Siegel, MD; Dominic A. Sisti, PhD; Arthur L. Caplan, PhD
On February 13, 2014, Belgium’s Parliament approved an amendment of the 2002 Belgium Act on Euthanasia to allow euthanasia for chronically ill children. The amendment, supported by a majority of Belgians and recently signed into law by King Philippe, permits euthanasia for children who are experiencing “constant and unbearable suffering.” ...
Viewpoint  FREE
David Orentlicher, MD, JD; Thaddeus Mason Pope, JD, PhD; Ben A. Rich, JD, PhD
While once widely rejected as a health care option, physician aid in dying is receiving increased recognition as a response to the suffering of patients at the end of life. With aid in dying, a physician writes a prescription for life-ending medication for an eligible patient. Following the recommendation of ...
Viewpoint  FREE
Farzad Mostashari, MD, MPH; Darshak Sanghavi, MD; Mark McClellan, MD, PhD
Even though most adult primary care physicians may not realize it, they each can be seen as a chief executive officer (CEO) in charge of approximately $10 million of annual revenue. Consider that a typical primary care physician has approximately 2000 patients, each of whom annually accounts for about $5000 ...
Viewpoint  FREE
David K. Jones, MSPH, MA; Phillip M. Singer, MHSA; John Z. Ayanian, MD, MPP
It has long been anticipated that 2014 would be the year in which most major elements of the Patient Protection and Affordable Care Act of 2010 (ACA) would be implemented.1 Yet even after surviving legislative, judicial, and electoral challenges, what the law actually will accomplish is uncertain. A major reason ...
Topics: medicaid
Viewpoint  FREE
Sachin H. Jain, MD, MBA; Michael Rosenblatt, MD; Jon Duke, MD, MS
Academic-industry research collaborations have long been a source of controversy in medicine. Advocates suggest that collaborations can focus academic researchers on important clinical and translational research problems and provide them with financial and capability-enhancing technical resources.1 Critics maintain that industry engagement distracts from, or distorts, the teaching and research missions ...
Research Letter  FREE
Masahiro Natsuaki, MD; Ken Kozuma, MD; Takeshi Morimoto, MD; Hiroki Shiomi, MD; Takeshi Kimura, MD
Recent network meta-analyses have raised concerns about the safety of biodegradable polymer drug-eluting stents (BP-DES) compared with durable polymer everolimus-eluting stents (DP-EES).1- 3 The NOBORI Biolimus-Eluting vs XIENCE/PROMUS Everolimus-Eluting Stent Trial (NEXT) is a 98-center, randomized, open-label, noninferiority trial evaluating the efficacy and safety of biodegradable polymer biolimus-eluting stents (BP-BES) ...
Viewpoint  FREE
Adam C. Powell, PhD; Adam B. Landman, MD; David W. Bates, MD
mHealth apps are mobile device applications intended to improve health outcomes, deliver health care services, or enable health research.1 The number of apps has increased substantially, and more than 40 000 health, fitness, and medical apps currently are available on the market.2 Because apps can be used to inexpensively promote ...
Viewpoint  FREE
Anthony S. Fauci, MD; Hilary D. Marston, MD, MPH
The emergence of multidrug-resistant bacteria and the rapid global spread of carbapenem-resistant Enterobacteriaceae (CRE) have recently captured public attention, and some have asked whether the ongoing public health and scientific “war” against drug-resistant microbes, particularly bacteria, can ever be won. In fact, the challenge of antimicrobial resistance is an enduring ...

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal